Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates...

[Free GPT-4]
[HTML] sciencedirect.com

[HTML][HTML] Real-world effectiveness and cardiovascular safety of abiraterone versus enzalutamide amongst older patients diagnosed with metastatic castration-resistant …

CE Gaber, E Okpara, AI Abdelaziz, J Sarker… - Journal of Geriatric …, 2025 - Elsevier
Introduction Abiraterone and enzalutamide are both approved in the United States for the
treatment of metastatic castration-resistant prostate cancer (mCRPC). The objective of this …
Save Cite Related articles All 3 versionsFree GPT-4